Overview

Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects

Status:
Completed
Trial end date:
2021-07-09
Target enrollment:
Participant gender:
Summary
Non-randomized, 3-part, open-label, drug-drug interaction (DDI) study to evaluate the effect of itraconazole, carbamazepine, or quinidine on the PK and safety of EDP-514 in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Enanta Pharmaceuticals
Collaborator:
PRA Health Sciences
Treatments:
Carbamazepine
Itraconazole
Quinidine